These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4560177)

  • 1. Levodopa in Parkinson's disease: effect on pulmonary function.
    Nakano KK; Bass H; Tyler HR
    Arch Intern Med; 1972 Sep; 130(3):346-8. PubMed ID: 4560177
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
    De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
    Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of fusaric acid in Parkinson's disease.
    Herskovits E; Figueroa Gacitua E
    Medicina (B Aires); 1973; 33(1):51-8. PubMed ID: 4573120
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled study of MK-486 in Parkinson's disease.
    Schwartz AM; Olanow CW; Spencer A
    Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
    [No Abstract]   [Full Text] [Related]  

  • 10. The causes of abnormal pulmonary function in Parkinson's disease.
    Obenour WH; Stevens PM; Cohen AA; McCutchen JJ
    Am Rev Respir Dis; 1972 Mar; 105(3):382-7. PubMed ID: 5011667
    [No Abstract]   [Full Text] [Related]  

  • 11. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical effects of para-chlorophenylalanine in Parkinson's disease.
    Van Woert MH; Ambani LM; Levine RJ
    Dis Nerv Syst; 1972 Dec; 33(12):777-80. PubMed ID: 4272666
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract]   [Full Text] [Related]  

  • 18. Levodopa in parkinson's disease--Australian collaborative trial.
    Selby G
    Med J Aust; 1973 Mar; 1(12):577-85. PubMed ID: 4700544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
    Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
    Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.